AI coding benchmark MirrorCode published its full results June 26, showing Claude Opus 4.7 autonomously rebuilt a 60,000-line interpreter and scored 56% overall — completing tasks that take human ...

Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox ...

Robert Kelly is managing director of XTS Energy LLC, and has more than three decades of experience as a business executive. He is a professor of economics and has raised more than $4.5 billion in ...

Clinical genetics involves the study, counselling and treatment of individuals and families with heritable disorders and disease predisposition. Diagnostic tools include standard ontologies for ...

Hasan, Leucht et al. undertook a drug repurposing trial evaluating the mineralocorticoid antagonist spironolactone as a treatment for cognitive impairment in people with schizophrenia. The primary ...

New commentary published in the Journal of the Royal Society of Medicine warns that current risk-based regulatory approaches to Artificial Intelligence (AI) in healthcare fall short in protecting ...

Scientists at The Wistar Institute have shown that a single injection of a small, circular piece of genetic instructions can produce weight loss and blood glucose control in murine models that lasts ...

Health news moves fast, with new studies, findings, and regulatory updates changing the landscape daily. Insights from advocates and celebrities can also impact the public awareness of certain health ...

Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome ...

Clinical Trials for Real-World Elderly Patients With Metastatic Soft-Tissue Sarcomas: The Importance of Study Design and Patient-Reported Outcomes ...

Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.

Prior authorization remains a major barrier to biologic access in AD. Dr Chuck Vega covers denial rates, appeal outcomes, and the clinical data that make the fight worthwhile.